Biosino Bio-Technology and Science Incorporation (HKG:8247)
3.500
0.00 (0.00%)
At close: Apr 29, 2026
HKG:8247 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -51.14 | -42.53 | -11.65 | 8.11 | -1.14 | Upgrade
|
| Depreciation & Amortization | 18.18 | 17.48 | 20.07 | 23.98 | 27.62 | Upgrade
|
| Other Amortization | 0.33 | 0.33 | 0.29 | 0.35 | 0.31 | Upgrade
|
| Loss (Gain) From Sale of Assets | 1.54 | 3.62 | 2.4 | 0.11 | 0.2 | Upgrade
|
| Asset Writedown & Restructuring Costs | 4.08 | 12.97 | 0.59 | - | 0.31 | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.33 | - | - | 0.71 | 0.27 | Upgrade
|
| Loss (Gain) on Equity Investments | -0.1 | 0.42 | -12.35 | -6.53 | -1.57 | Upgrade
|
| Provision & Write-off of Bad Debts | 4.67 | 5.66 | 0.57 | 0.47 | -0.23 | Upgrade
|
| Other Operating Activities | -8.16 | -7.68 | -3.49 | 15.5 | 28.58 | Upgrade
|
| Change in Accounts Receivable | 10.19 | 52.59 | 35.14 | -8.53 | -2.63 | Upgrade
|
| Change in Inventory | 7.45 | 5.42 | -16.02 | -1.92 | -6.65 | Upgrade
|
| Change in Accounts Payable | -24.44 | -24.43 | -25.47 | -8.66 | 20.55 | Upgrade
|
| Change in Unearned Revenue | - | -0.07 | -0.76 | -1.63 | -0.93 | Upgrade
|
| Change in Other Net Operating Assets | 11.21 | -0.02 | 4.11 | 22.58 | -15.8 | Upgrade
|
| Operating Cash Flow | -25.84 | 23.75 | -6.56 | 44.53 | 48.89 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | -8.93% | 329.91% | Upgrade
|
| Capital Expenditures | -6.54 | -12.39 | -16.35 | -16.34 | -3.74 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.28 | 0.47 | 0.38 | 0.37 | 0.55 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.23 | -2.83 | -0.23 | -0.14 | -2.81 | Upgrade
|
| Investment in Securities | -0.02 | -0.55 | - | - | - | Upgrade
|
| Other Investing Activities | 1.96 | 3.46 | -1.5 | 14.98 | 0.22 | Upgrade
|
| Investing Cash Flow | -4.55 | -11.85 | -17.7 | -1.12 | -5.78 | Upgrade
|
| Long-Term Debt Issued | 155.65 | 149.95 | 143.87 | 161.41 | 178.89 | Upgrade
|
| Total Debt Issued | 155.65 | 149.95 | 143.87 | 161.41 | 178.89 | Upgrade
|
| Long-Term Debt Repaid | -146.82 | -148.12 | -144.73 | -187.04 | -212.34 | Upgrade
|
| Total Debt Repaid | -146.82 | -148.12 | -144.73 | -187.04 | -212.34 | Upgrade
|
| Net Debt Issued (Repaid) | 8.83 | 1.83 | -0.86 | -25.62 | -33.46 | Upgrade
|
| Other Financing Activities | -3.07 | -8.88 | 11.11 | 14.87 | -10.57 | Upgrade
|
| Financing Cash Flow | 5.76 | -7.05 | 10.25 | -10.76 | -44.02 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.07 | -0.05 | 0.07 | 0.22 | -0.08 | Upgrade
|
| Net Cash Flow | -24.69 | 4.8 | -13.94 | 32.88 | -0.98 | Upgrade
|
| Free Cash Flow | -32.39 | 11.36 | -22.91 | 28.19 | 45.15 | Upgrade
|
| Free Cash Flow Growth | - | - | - | -37.56% | - | Upgrade
|
| Free Cash Flow Margin | -17.57% | 4.32% | -7.92% | 7.56% | 12.97% | Upgrade
|
| Free Cash Flow Per Share | -0.22 | 0.08 | -0.16 | 0.20 | 0.31 | Upgrade
|
| Cash Interest Paid | 6.57 | 8.88 | 5.4 | 6.13 | 10.57 | Upgrade
|
| Cash Income Tax Paid | 1.73 | 1.89 | 5.81 | 5.15 | 2.66 | Upgrade
|
| Levered Free Cash Flow | -19.2 | 12.18 | -11.9 | 44.77 | 20.58 | Upgrade
|
| Unlevered Free Cash Flow | -14.94 | 17.99 | -7.9 | 49.04 | 27.18 | Upgrade
|
| Change in Working Capital | 4.41 | 33.49 | -3 | 1.84 | -5.45 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.